Only the quickest can keep up in this race. Although avian influenza inhibitors such as Tamiflu or Relenza have only been on the market for a few years, experts have already observed the first viral strains that are resistant to these compounds. The danger of a pandemic is actually quite real; the avian influenza pathogen could, at any time, evolve into a dangerous human pathogen. About a year ago, Prof. Dr. Martin Schwemmle and his team in the Department of Virology at the University Hospital of Freiburg, discovered a completely new starting point in the fight against these dangerous viruses. In the meantime, the scientists are working together with the Zurich-based company Pike Pharma to develop a compound that might be effective over longer periods of time.